
The Cannabis &
Psychedelics Investment Summit
A Family Office Series
September 20, 2022
BMA House
London, UK
Speakers
Join our industry experts, entrepreneurs, and investors as they discuss the critical topics investors should consider.

Entrepreneur and Investor

Sapphire Clinics

Operating Partner, KindRun

Chief Executive Officer, SWISS Gate AG

Enexis AB

Partner, Chrystal Capital Partners

CEO & Co-Founder, Skip Intro

President, Pelorus Equity Group, Inc.

Head of Chrystal Capital Health & Wellness, Chrystal Capital Partners LLP

CEO, The Liaison Group

Partner, Saul Ewing Arnstein & Lehr LLP

Managing Director, Cantourage

Co-Founder & Head of Psychedelic Medicine at Awakn Life Sciences

Co-Founder & CEO, Djot

Artemis Growth Partners

Canna Capital PLC

Business Consultant

CEO, Seed Innovations

CEO, Ola Verde

Co-Founder and Investment Manager at Óskare Capital

Mayor of Lewisham

The Cannabis Conversation

Senior Partner, Memery Crystal

Co-Founder, Managing Director & CEO at MGC Pharmaceuticals

Director of Engagement ICEERS

Anthony Legge, MBU Capital
Agenda
9:00am-10:00am
Breakfast, Registration & Mingling
Sponsored by: Greenspoon Marder
10:00am-10:10am
Master of Ceremonies Opening Remarks:
Noa Kahner, CEO, Kahner Global
10:10am-10:55am
A Legal Overview: The Future of Cannabis Policy
Moderator:
Anuj Desai, The Cannabis Conversation
Panelists:
Saphira Galoob, Executive Director, National Cannabis Roundtable
Jonathan Havens, Attorney, Saul Ewing Arnstein & Lehr LLP
Damien Egan, Mayor of Lewisham
11:00am-11:40am
Germany and North America: Market Opportunities in the Rec Space
Moderator:
Bijan Christoph Hezarkhani, Cannabis Consultant
Panelists:
Julia Germaine, Operating Partner, KindRun
Philip Schetter, Managing Director, Cantourage
11:40am-12:20pm
Medicinal Cannabis and CBD
Moderator:
Tom Grebenstein, CEO, Ola Verde
Panelists:
Dr. Mikael H Sodergren, Managing Director & Academic Lead, Sapphire Clinics
Roby Zomer, Co-Founder, Managing Director & CEO, MGC Pharmaceuticals
12:25pm- 1:00pm
Investor Pitch Session
3-4 companies will each pitch for 8 minutes followed by a Q&A from our judges
Judges:
Stanton McLean, Artemis Growth Partners
Adhum Carter Wolde-lule, CEO, Canna Capital PLC
Oliver Lamb, Investment Manager, Oskare Capital
Companies:
Marco Hoffmann, Chief Executive Officer, SWISS Gate AG
Elad Barak, Co-Founder & CEO, DJOT
Philip Schetter, Managing Director, Cantourage
1:00pm-2:00pm
Networking Lunch
Sponsored by: GreenspoonMarder
2:00pm-2:45pm
M&A & Capital Markets
Moderator:
Tristan Gervais, Head of Chrystal Capital Cannabis Advisory, Chrystal Capital Partners LLP
Panelists:
Ed McDermott, Co-founder, EMMAC; CEO, Seed Innovations
Nick Davis, Senior Partner, Memery Crystal
Roby Zomer, Co-Founder, Managing Director & CEO, MGC Pharmaceuticals
2:45pm-3:00pm
Fireside Chat:
Rob Sechrist, President, Pelorus Equity Group
Moderator:
Anuj Desai, The Cannabis Conversation
3:00pm-3:15pm
Refreshment Break
Sponsored by: GreenspoonMarder
3:20pm-4:00pm
Investing in Psychedelic Medicine
Moderator:
David N. Feldman, CEO and Co-Founder, Skip Intro Advisors LLC
Panelists:
Bruce Linton, Investor
Dr Ben Sessa, Approved Psychedelic Therapist, Chief Medical Officer, AWAKN Life Sciences
Andrea Langlois, IMC Fund
4:00pm-4:40pm
Investment 101 for Family Offices
-
Why are family offices best positioned to win in this phase of the cannabis industry?
-
How have options for investments evolved over time?
-
International Investment Opportunities
Moderator:
Amine Nedjai, CEO, Alpha Blue Ocean
Panelists:
David Bonnier, Founding Partner, Enexis AB
Anthony Legge, MBU Capital
4:40pm-5:40pm
Cocktail Reception
Sponsored by: Ola Verde
Contact Us
This prestigious event will provide select sponsors an opportunity to interact with a curated group of hight net worth investors and family offices. For more info, please contact us at info@kahnerglobal.com or fill out the form below.